Mirum Pharmaceuticals, Inc. (MIRM)
86.01
+4.66
(+5.73%)
USD |
NASDAQ |
Oct 09, 16:00
85.90
-0.12
(-0.13%)
After-Hours: 20:00
Mirum Pharmaceuticals Free Cash Flow : -263.74M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -263.74M |
| March 31, 2026 | -182.55M |
| December 31, 2025 | 54.87M |
| September 30, 2025 | 44.32M |
| June 30, 2025 | -1.373M |
| March 31, 2025 | -27.87M |
| December 31, 2024 | -10.67M |
| September 30, 2024 | -27.20M |
| June 30, 2024 | -39.22M |
| March 31, 2024 | -42.04M |
| December 31, 2023 | -91.05M |
| September 30, 2023 | -103.95M |
| June 30, 2023 | -111.77M |
| March 31, 2023 | -114.56M |
| Date | Value |
|---|---|
| December 31, 2022 | -120.41M |
| September 30, 2022 | -138.05M |
| June 30, 2022 | -146.23M |
| March 31, 2022 | -166.24M |
| December 31, 2021 | -151.78M |
| September 30, 2021 | -135.94M |
| June 30, 2021 | -119.22M |
| March 31, 2021 | -96.06M |
| December 31, 2020 | -89.30M |
| September 30, 2020 | -66.76M |
| June 30, 2020 | -64.65M |
| March 31, 2020 | -55.62M |
| December 31, 2019 | -39.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Incyte Corp. | 1.890B |
| Insmed, Inc. | -837.67M |
| Galectin Therapeutics, Inc. | -15.89M |
| Kodiak Sciences, Inc. | -159.90M |
| Praxis Precision Medicines, Inc. | -306.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.25M |
| Cash from Investing (Quarterly) | -159.99M |
| Cash from Financing (Quarterly) | 211.44M |
| Free Cash Flow Per Share (Quarterly) | -1.093 |
| Free Cash Flow to Equity (Quarterly) | -508.44M |
| Free Cash Flow to Firm (Quarterly) | -66.59M |
| Free Cash Flow Yield | -5.31% |